<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Curr Eye Res</journal-id>
      <journal-id journal-id-type="publisher-id">ncer</journal-id>
      <journal-title-group>
        <journal-title>Current Eye Research</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0271-3683</issn>
      <issn pub-type="epub">1460-2202</issn>
      <publisher>
        <publisher-name>Informa Healthcare</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3021952</article-id>
      <article-id pub-id-type="pmid">21158584</article-id>
      <article-id pub-id-type="doi">10.3109/02713683.2010.534229</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Molecular Epidemiology of Methicillin-Resistant and Methicillin-Susceptible <italic>Staphylococcus aureus</italic> Isolated from the Eye</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hesje</surname>
            <given-names>Christine K</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sanfilippo</surname>
            <given-names>Christine M</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haas</surname>
            <given-names>Wolfgang</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Morris</surname>
            <given-names>Timothy W</given-names>
          </name>
        </contrib>
        <aff>Bausch &amp; Lomb, Inc., Rochester, New York</aff>
      </contrib-group>
      <author-notes>
        <corresp>Correspondence: Christine K. Hesje, 1400 N Goodman Street, Rochester, NY 14609. E-mail: <email>christine.hesje@bausch.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>12</month>
        <year>2010</year>
      </pub-date>
      <volume>36</volume>
      <issue>2</issue>
      <fpage>94</fpage>
      <lpage>102</lpage>
      <history>
        <date date-type="received">
          <day>10</day>
          <month>8</month>
          <year>2010</year>
        </date>
        <date date-type="accepted">
          <day>10</day>
          <month>10</month>
          <year>2010</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2011 Informa Healthcare USA, Inc.</copyright-statement>
        <copyright-year>2011</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>This is an open access article distributed under the <ext-link ext-link-type="uri" xlink:href="http://www.informaworld.com/mpp/uploads/iopenaccess_tcs.pdf">Supplemental Terms and Conditions for iOpenAccess articles published in Informa Healthcare journals</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose:</title>
          <p>Methicillin-resistant <italic>Staphylococcus aureus</italic> (MRSA) strains are commonly classified as hospital-acquired (HA) or community-acquired (CA). Typical HA-MRSA isolates are characterized by multidrug resistance and the SCC<italic>mec</italic> type II cassette, while CA-MRSA isolates are generally susceptible to more drug classes, are often of SCC<italic>mec</italic> type IV, and frequently carry the Panton-Valentine leukocidin (PVL) genes. This study determined the presence of traits characteristic for CA and HA strains in ocular MRSA isolates.</p>
        </sec>
        <sec>
          <title>Materials and Methods:</title>
          <p>Fifty-six recent ocular isolates, consisting of 40 MRSA and 16 methicillin-susceptible <italic>Staphylococcus aureus</italic> (MSSA) comparator strains, were characterized. Minimum inhibitory concentration (MIC) testing was done according to current Clinical and Laboratory Standards Institute guidelines. Detection of the PVL encoding genes and determination of the SCC<italic>mec</italic> type was done by polymerase chain reaction (PCR), while <italic>spa</italic> typing and cluster analysis was performed following DNA sequencing.</p>
        </sec>
        <sec>
          <title>Results:</title>
          <p>Of the 38 typeable MRSA isolates, 22 were of SCC<italic>mec</italic> type II and 16 were of SCC<italic>mec</italic> type IV. All SCC<italic>mec</italic> type II isolates were multidrug-resistant, lacked the PVL genes, and were of <italic>spa</italic> type t002 or closely related <italic>spa</italic> types. In contrast, the SCC<italic>mec</italic> type IV isolates were resistant to fewer classes of antimicrobial agents, often possessed the PVL genes (75.0%), and were of <italic>spa</italic> type t008 or closely related <italic>spa</italic> types.</p>
        </sec>
        <sec>
          <title>Conclusions:</title>
          <p>While the majority of ocular MRSA strains in this study fit the classical profile of HA-and CA-MRSA, some CA-MRSA isolates exhibited higher levels of antimicrobial resistance, which should be of particular concern to eye-care professionals. Furthermore, the apparent association of <italic>spa</italic> types and SCC<italic>mec</italic> types observed here warrants further investigation and suggests that <italic>spa</italic> typing may be useful in future HA- and CA-MRSA characterization studies.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Bacterial infection</kwd>
        <kwd>Community-acquired MRSA</kwd>
        <kwd>Multi-drug resistance</kwd>
        <kwd><italic>spa</italic> typing</kwd>
        <kwd>Staphylococcal virulence factors</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="">
      <title>INTRODUCTION</title>
      <p><italic>Staphylococcus aureus</italic> is a leading human pathogen of significant clinical importance, responsible for a wide array of infections from superficial skin infections to more serious invasive infections, including pneumonia, septicemia, and endocarditis. It is also one of the most common ophthalmic pathogens recovered from conjunctivitis and other ocular infections.<xref ref-type="bibr" rid="b1">1</xref> Since the isolation of the first methicillin-resistant <italic>S. aureus</italic> (MRSA) in 1961,<xref ref-type="bibr" rid="b2">2</xref> the increasing prevalence of MRSA worldwide has become a growing concern,<xref ref-type="bibr" rid="b3">3</xref>,<xref ref-type="bibr" rid="b4">4</xref> prompting the typing of <italic>S. aureus</italic> in order to support infection control measures, investigate suspected outbreaks, and evaluate nosocomial transmission.</p>
      <p>Historically, MRSA pathogens were almost exclusively isolated from hospitals or hospital-associated facilities. However, there have been an increasing number of MRSA cases reported in individuals with no known risk factors for MRSA colonization, such as admission to a hospital, surgery, contact with a MRSA-colonized patient, intravenous drug use, or previous antibiotic exposure.<xref ref-type="bibr" rid="b5">5</xref>,<xref ref-type="bibr" rid="b7">7</xref> These isolates, termed community-acquired MRSA (CA-MRSA), have become a global concern and have been found worldwide not only in the community setting but also in healthcare facilities.<xref ref-type="bibr" rid="b8">8</xref> In fact, some hospitals have reported a predominance of CA-MRSA isolates over hospital-acquired MRSA (HA-MRSA) isolates.<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b10">10</xref> Although the term &#x201C;acquired&#x201D; implies that the location of transmission is known, the HA- and CA-designations have also been used to describe the phenotypic and molecular traits of MRSA isolates, as we have done in this study.</p>
      <p>HA-MRSA strains, exemplified by the USA100 clone, are typically associated with nosocomial infections including bacteremia,<xref ref-type="bibr" rid="b11">11</xref> whereas CA-MRSA strains, exemplified by the USA300 clone, have been more commonly associated with skin and soft tissue infections.<xref ref-type="bibr" rid="b9">9</xref>,<xref ref-type="bibr" rid="b12">12</xref>,<xref ref-type="bibr" rid="b13">13</xref> The two groups are also distinguished by differences in their susceptibilities to antimicrobial agents, the composition of the gene cassette coding for methicillin resistance, and associated exotoxin profiles. Because CA-MRSA and HA-MRSA isolates are different with respect to virulence and antimicrobial susceptibility profiles, this information could be useful in the design of future strategies to prevent and treat ocular infections.</p>
      <p>In contrast to HA-MRSA, which generally possess multiple antimicrobial resistance determinants and are thus multidrug-resistant, CA-MRSA are typically susceptible to non-&#x3B2;-lactam antibiotics.<xref ref-type="bibr" rid="b14">14</xref> Resistance to &#x3B2;-lactam antibiotics, including methicillin, is conferred by a low affinity penicillin-binding protein (PBP) 2a, encoded by the <italic>mecA</italic> gene. The <italic>mecA</italic> gene is found on a mobile genetic element known as the &#x201C;staphy-lococcal cassette chromosome <italic>mec</italic>&#x201D; (SCCmec).<xref ref-type="bibr" rid="b15">15</xref>&#x2013;<xref ref-type="bibr" rid="b17">17</xref> To date, eight major variants of SCC<italic>mec</italic> (type I to VIII) have been identified,<xref ref-type="bibr" rid="b18">18</xref> with SCC<italic>mec</italic> type II and type IV found predominantly in HA-MRSA and CA-MRSA, respectively.<xref ref-type="bibr" rid="b19">19</xref>&#x2013;<xref ref-type="bibr" rid="b21">21</xref> The Panton-Valentine leukocidin (PVL) genes, coding for a pore-forming cytotoxin known to cause tissue necrosis and leukocyte destruction, are frequently present in CA-MRSA and have been shown to be stable markers of CA-MRSA cases worldwide.<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b22">22</xref>&#x2013;<xref ref-type="bibr" rid="b24">24</xref> In fact, CA-MRSA has been shown to be more virulent compared to HA-MRSA due to the presence of various virulence factors, such as PVL.<xref ref-type="bibr" rid="b4">4</xref>,<xref ref-type="bibr" rid="b17">17</xref>,<xref ref-type="bibr" rid="b25">25</xref>,<xref ref-type="bibr" rid="b26">26</xref> Both SCC<italic>mec</italic> typing and detection of the PVL locus are useful tools for the molecular characterization of HA- and CA-MRSA isolates.</p>
      <p>A different tool used for the typing of both MRSA and MSSA is single locus DNA sequencing of the <italic>S. aureus</italic> Protein A gene variable repeat region <italic>(spa</italic> typing). The <italic>spa</italic> gene contains a hypervariable region that differs in the number of repeats (1 to 23) and the number of base pairs (21 to 30) in each repeat (<ext-link ext-link-type="uri" xlink:href="http://spaserver.ridom.de">http://spaserver.ridom.de</ext-link>, accessed 20 Jul 2010).<xref ref-type="bibr" rid="b27">27</xref>,<xref ref-type="bibr" rid="b28">28</xref> The nucle-otide composition of each distinct repeat is determined and subsequently given a <italic>spa</italic> type designation based on the unique succession of repeats. To date, pulsed-field gel electrophoresis (PFGE) is frequently used to determine clonal relationships between bacterial isolates. However, the method is cumbersome and PFGE results cannot be easily compared among multiple laboratories.<xref ref-type="bibr" rid="b29">29</xref> In contrast, the <italic>spa</italic> typing method, along with the recently described <italic>spa</italic> grouping algorithm BURP (Based Upon Repeat Patterns), provides a rapid and accurate method to determine clonal relationships among <italic>S. aureus</italic> strains.<xref ref-type="bibr" rid="b29">29</xref>&#x2013;<xref ref-type="bibr" rid="b31">31</xref></p>
      <p>While much attention has been paid to MRSA isolates from skin, soft tissue, and invasive infections, less is known about the prevalence and epidemiology of MRSA in infections of the eye. Since commensal bacteria from the skin and nasopharynx are often the source of ocular infections and CA-MRSA often cause skin and soft tissue infections, it was of interest to determine whether strains that have traits similar to those of HA-MRSA or those of CA-MRSA are more prevalent among drug-resistant isolates from ocular infections. As part of an ongoing study to characterize fluoroquinolone (FQ) resistance in ocular <italic>S. aureus</italic> isolates, we chose to further characterize such isolates with respect to the microbiological and molecular features of CA- and HA-MRSA isolated in the USA. Accordingly, SCC<italic>mec</italic> typing, the presence of the PVL gene, and antimicrobial susceptibility testing were used to characterize these strains for traits typical of either CA-MRSA or HA-MRSA. <italic>Spa</italic> typing was also performed to explore its use as a potential method for characterizing HA-MRSA and CA-MRSA strains.</p>
    </sec>
    <sec sec-type="materials|methods">
      <title>MATERIALS AND METHODS</title>
      <sec>
        <title>Bacterial Strains and Growth Conditions</title>
        <p>As part of a separate study to characterize the molecular basis of high-level FQ resistance among staphylo-cocci, a total of 56 ocular <italic>S. aureus</italic> strains including MRSA and MSSA were obtained from Eurofins Medinet (Chantilly, Virginia, USA). Ocular isolates were collected between 2006 and 2008, representing 24 hospitals from 14 different U.S. states. Strains were isolated from one of four different ocular sources (aqueous fluid, vitreous fluid, conjunctiva, or cornea) from patients aged &lt; 1 to 90 years (61% female). Care was taken to ensure that no duplicate isolates were included in this study.</p>
        <p>All strains were grown for 18-24 hr at 37&#xB0;C under ambient conditions. For genomic DNA extractions, bacteria were grown in Tryptic Soy Broth (Difco, Sparks, Maryland). Susceptibility testing was performed with Mueller-Hinton Broth II (Difco). ATCC 29213 (American Type Culture Collection [ATCC], Manassas, Virginia, USA) was the <italic>S. aureus</italic> quality control strain used for Clinical Laboratory and Standards Institute (CLSI) compliant susceptibility testing.<xref ref-type="bibr" rid="b32">32</xref> Two MRSA strains, USA300 and USA600 (ATCC), were used as controls for SCC<italic>mec</italic> typing.</p>
      </sec>
      <sec>
        <title>Antimicrobial Susceptibility Testing</title>
        <p>In vitro antimicrobial susceptibility testing for besifloxacin (BES), moxifloxacin (MXF), gatifloxa-cin (GAT), ciprofloxacin (CIP), levofloxacin (LVX), azithromycin (AZI), vancomycin (VAN), rifampin (RIF), clindamycin (CLI), tobramycin (TOB), erythromycin (ERY), tetracycline (TET), linezolid (LIN), and oxacillin (OXA) was performed according to CLSI guidelines.<xref ref-type="bibr" rid="b32">32</xref> All agents were obtained in powder form from LKT Laboratories (St. Paul, Minnesota, USA), with the exception of BES, which was obtained from Bausch &amp; Lomb Inc. (Rochester, New York, USA). In accordance with the manufacturer's recommendations, all agents were solubilized and diluted. The minimum inhibitory concentration (MIC) was reported as the lowest antimicrobial concentration that inhibited the visible growth of bacteria. Since susceptibility test interpretive criteria (breakpoints) have yet to be defined by the Food and Drug Administration (FDA) or CLSI for topical agents, systemic breakpoints were used, where available, to classify bacterial isolates as susceptible or resistant. Because besifloxacin was developed as an exclusively topical ophthalmic agent, no breakpoints are currently defined.</p>
      </sec>
      <sec>
        <title><italic>spa</italic> Typing and BURP Cluster Analysis</title>
        <p>Genomic DNA was extracted from pure bacterial cultures using the Wizard Genomic DNA Purification Kit (Promega, Madison, Wisconsin, USA) according to the manufacturer's instructions and was used as the template for polymerase chain reaction (PCR) amplification. The <italic>spa</italic> variable repeat region from each isolate was amplified using previously published oligonucleotide primers.<xref ref-type="bibr" rid="b33">33</xref> PCR was carried out in a MyCycler thermal cycler (BioRad, Hercules, California, USA) in a 100 &#x3BC;l volume containing 0.4 &#x3BC;M primers (Integrated DNA Technologies, Coralville, Iowa, USA), 200 &#x3BC;M deoxynucleoside triphosphates (Omega Bio-Tek, Norcross, Georgia, USA), 1U of Vent DNA polymerase and its reaction buffer containing 2mM magnesium sulfate (New England Biolabs, Ipswich, Massachusetts, USA). The initial cycle of denaturation (15min at 94&#xB0;C) preceded 30 cycles consisting of 0.5 min of denaturation at 94&#xB0;C, 1 min of annealing at 59&#xB0;C, and 1 min of elongation at 72&#xB0;C, and was followed by a final cycle of elongation (10 min at 72&#xB0;C). PCR products were purified using the EZNA Cycle Pure Kit (Omega Bio-Tek), and sequenced by ACGT Inc. (Wheeling, Illinois, USA). Clone Manager 9 (Sci-Ed Software, Cary, North Carolina, USA) was used for sequence analyses, and <italic>spa</italic> types were determined using the website (<ext-link ext-link-type="uri" xlink:href="http://spaserver.ridom.de/">http://spaserver.ridom.de/</ext-link>) developed by Ridom GmbH and curated by SeqNet.org (<ext-link ext-link-type="uri" xlink:href="http://SeqNet.org/">http://SeqNet.org/</ext-link>).<xref ref-type="bibr" rid="b28">28</xref> The BURP clustering tool in the Ridom StaphType 2.0.3 software package (Ridom GmbH, W&#xFC;rzburg, Germany) was used for <italic>spa</italic> type aligning and clustering.<xref ref-type="bibr" rid="b31">31</xref></p>
      </sec>
      <sec>
        <title>Detection of Genes Encoding PVL</title>
        <p>Genomic DNA was extracted as described above and used as the template for PCR amplification. A 945-bp region of the Panton-Valentine leukocidin genes <italic>(lukF-PV</italic> and <italic>lukS-PV)</italic> from each isolate was amplified using the oligonucleotide primers, <italic>lukS</italic> 5'-CCC ATT AGT ACA CAG TGG TTT CAA TC-3&#x2019; and <italic>lukF</italic> 5'-GTC CAG CAT TTA AGT TGC TTT GTC-3'. The primer sequences were designed from the published <italic>S. aureus</italic> strain USA300 (GenBank accession no. NC_007793) using Clone Manager 9 analysis software (Sci-Ed Software). PCR was carried out as described above in a 25 &#x3BC;l volume. The initial cycle of denaturation (10 min at 94&#xB0;C) preceded 33 cycles consisting of 0.5 min of denaturation at 94&#xB0;C, 0.5 min of annealing at 57&#xB0;C, and 1 min of elongation at 72&#xB0;C, and was followed by a final cycle of elongation (10min at 72&#xB0;C).</p>
      </sec>
      <sec>
        <title>SCCmec Typing</title>
        <p>Genomic DNA was extracted as described by Zhang et al.<xref ref-type="bibr" rid="b34">34</xref> with modifications. Briefly, five to ten bacterial colonies were suspended in 50 &#x3BC;l of nuclease-free water (Promega) and heated at 99&#xB0;C for 10 min. After cen-trifugation at 21,000 &#xD7; <italic>g</italic> for 1 min, 2.5-9 &#x3BC;l of the supernatant was used as the template for PCR amplification. The SCC<italic>mec</italic> typing assay contained eight unique and specific pairs of primers as previously described<xref ref-type="bibr" rid="b35">35</xref> for SCCmec types and subtypes I, II, III, IVa, IVb, IVc, IVd, and V. PCR was carried out as simplex reactions using conditions identical to those described above for PVL detection.</p>
      </sec>
      <sec>
        <title>Gel Electrophoresis</title>
        <p>PCR amplicons were visualized using a UV light box after electrophoresis on 1% <italic>(spa</italic> typing) or 2% (detection of PVL genes and SCC<italic>mec</italic> typing) agarose gels containing 0.1 ug/ml ethidium bromide (Omega Bio-Tek).</p>
      </sec>
    </sec>
    <sec sec-type="">
      <title>RESULTS</title>
      <p>Published CLSI breakpoints for OXA<xref ref-type="bibr" rid="b36">36</xref> were used to classify all ocular <italic>S. aureus</italic> isolates as either MSSA (n = 16) or MRSA (n = 40). With the exception of two MRSA isolates, where the SCC<italic>mec</italic> type could not be determined, the remaining 38 MRSA isolates were classified as either SCC<italic>mec</italic> type II (n=22) or type IV (n = 16) (<xref ref-type="table" rid="tbl1">Table 1</xref>). Two different subtypes of the SCC<italic>mec</italic> type IV cassette were found with subtype IVa identified in 15 (93.8%) of the type IV isolates and subtype IVb being found in a single isolate (6.3%). The PVL genes were absent in all SCC<italic>mec</italic> type II isolates, while 75.0% (12/16) of SCC<italic>mec</italic> type IV and 18.8% (3/16) of the MSSA isolates contained the PVL genes. Four different, but related, <italic>spa</italic> types were found among SCC<italic>mec</italic> type II isolates while five different, but related, <italic>spa</italic> types were found among SCC<italic>mec</italic> type IV isolates; MSSA was the most diverse with respect to <italic>spa</italic> type with 12 different types being observed.</p>
      <table-wrap id="tbl1" position="float">
        <label>TABLE 1</label>
        <caption>
          <p>Summary of ocular <italic>S. aureus</italic> characteristics.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th colspan="2" align="center" rowspan="1">MRSA<hr/></th>
              <th rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th align="center" rowspan="1" colspan="1">Type II</th>
              <th align="center" rowspan="1" colspan="1">Type IV</th>
              <th align="center" rowspan="1" colspan="1">MSSA</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Number of isolates</td>
              <td align="center" rowspan="1" colspan="1">22</td>
              <td align="center" rowspan="1" colspan="1">16</td>
              <td align="center" rowspan="1" colspan="1">16</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Source of isolates by state (number of sites)</td>
              <td align="center" rowspan="1" colspan="1">AL (2), FL (1), GA (1), ID (1), MA (2), MD (1), MI (3), NY (2), OH (2), PA (4), SC (1), TN (2)</td>
              <td align="center" rowspan="1" colspan="1">FL (1), GA (1), ID (1), MA (1), MD (4), MI (1), NC (1), NY (2), OH (4)</td>
              <td align="center" rowspan="1" colspan="1">AL (1), FL (2), GA (1), MA (2), MD (1), MI (1), MO (1), NY (3), OH (2), PA (2)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">SCCmec type (n)</td>
              <td align="center" rowspan="1" colspan="1">II (22)</td>
              <td align="center" rowspan="1" colspan="1">IVa (15)</td>
              <td align="center" rowspan="1" colspan="1">NA</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td rowspan="1" colspan="1"/>
              <td align="center" rowspan="1" colspan="1">IVb(1)</td>
              <td rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">PVL positive, n (%)</td>
              <td align="center" rowspan="1" colspan="1">0 (0.0%)</td>
              <td align="center" rowspan="1" colspan="1">12 (75.0%)</td>
              <td align="center" rowspan="1" colspan="1">3 (18.8%)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Number of <italic>spa</italic> types</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">5</td>
              <td align="center" rowspan="1" colspan="1">12</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 1+ drug class<xref ref-type="table-fn" rid="tf1-1">a</xref></td>
              <td align="center" rowspan="1" colspan="1">100.0%</td>
              <td align="center" rowspan="1" colspan="1">100.0%</td>
              <td align="center" rowspan="1" colspan="1">62.5%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 2+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">100.0%</td>
              <td align="center" rowspan="1" colspan="1">93.8%</td>
              <td align="center" rowspan="1" colspan="1">37.5%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 3+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">100.0%</td>
              <td align="center" rowspan="1" colspan="1">62.5%</td>
              <td align="center" rowspan="1" colspan="1">18.8%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 4+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">95.5%</td>
              <td align="center" rowspan="1" colspan="1">6.3%</td>
              <td align="center" rowspan="1" colspan="1">6.3%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 5+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">36.4%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 6+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">4.5%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">% Resistant to 7+ drug classes</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
              <td align="center" rowspan="1" colspan="1">0.0%</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tf1-1">
            <label>a</label>
            <p>Drug classes tested included fluoroquinolones, macrolides, lincosamides, aminoglycosides, tetracyclines, rifamycins, glycopeptides, oxazolidinones, &#x3B2;-lactams.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Susceptibility testing was performed with 14 antimicrobial agents representing the following nine drug classes: fluoroquinolones (FQs), macrolides, lincos-amides, aminoglycosides, tetracyclines, rifamycins, glycopeptides, oxazolidinones, and &#x3B2;-lactams. All SCC<italic>mec</italic> type II isolates were resistant to at least three drug classes, with one isolate in this group exhibiting resistance to six different drug classes. Conversely, 62.5% of SCC<italic>mec</italic> type IV isolates were resistant to at least three drug classes, with no isolate in this group possessing resistance to more than four different drug classes.</p>
      <p>The MIC<sub>50</sub>, MIC<sub>90</sub>, and MIC range values for all antimicrobial agents tested are presented in <xref ref-type="table" rid="tbl2">Table 2</xref>. One hundred percent of all <italic>S. aureus</italic> isolates were susceptible to the systemic (i.e., non-ophthalmic) agents RIF, VAN, and LIN. Additionally, 100% of the SCCmec type IV isolates were susceptible to CLI and TET while 87.5% and 93.8% of MSSA isolates and 54.5% and 95.5% of the SCCmec type II isolates were susceptible to these drugs, respectively. With the exception of BES, where the percentage of susceptible isolates cannot be determined due to the lack of any established resistance breakpoints for exclusively topical agents, all SCC<italic>mec</italic> type II isolates were resistant to the FQs (MXF, GAT, CIP, and LVX) and macrolides (AZI and ERY) tested. However, 37.5% and 6.3% of SCC<italic>mec</italic> type IV isolates were susceptible to all FQs and macrolides tested, respectively; 56.3% of MSSA isolates were susceptible to the macrolides and early generation FQs (CIP and LVX), while 62.5% of MSSA isolates were susceptible to the subsequent generation of FQ agents (GAT and MXF). While only 13.6% of SCC<italic>mec</italic> type II isolates were susceptible to TOB, 93.8% of SCC<italic>mec</italic> type IV isolates and 81.3% of MSSA isolates exhibited susceptibility to this aminoglycoside.</p>
      <table-wrap id="tbl2" position="float">
        <label>TABLE 2</label>
        <caption>
          <p>Antimicrobial susceptibilities of ocular <italic>S. aureus,</italic> including 16 MSSA, 22 MRSA <italic>SCCmec</italic> type II, and 16 MRSA <italic>SCCmec</italic> type IV isolates.</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1"/>
              <th rowspan="1" colspan="1"/>
              <th colspan="3" align="center" rowspan="1">MIC (ng/ml)<hr/></th>
              <th rowspan="1" colspan="1"/>
            </tr>
            <tr>
              <th align="left" rowspan="1" colspan="1">Agent</th>
              <th align="left" rowspan="1" colspan="1">Organism</th>
              <th align="center" rowspan="1" colspan="1">Range</th>
              <th align="center" rowspan="1" colspan="1">50%</th>
              <th align="center" rowspan="1" colspan="1">90%</th>
              <th align="center" rowspan="1" colspan="1">% Susceptible</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left" rowspan="1" colspan="1">Besifloxacin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.016-4</td>
              <td align="center" rowspan="1" colspan="1">0.03</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">NA<xref ref-type="table-fn" rid="tf2-1">a</xref></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">0.5-8</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">NA<xref ref-type="table-fn" rid="tf2-1">a</xref></td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.016-1</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">NA<xref ref-type="table-fn" rid="tf2-1">a</xref></td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Moxifloxacin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.03-64</td>
              <td align="center" rowspan="1" colspan="1">0.06</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">62.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">2-64</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">64</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.016-2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">37.5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Gatifloxacin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.06-64</td>
              <td align="center" rowspan="1" colspan="1">0.125</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">62.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">2-128</td>
              <td align="center" rowspan="1" colspan="1">64</td>
              <td align="center" rowspan="1" colspan="1">128</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.031-2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">37.5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Ciprofloxacin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.125-256</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">56.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">32-256</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.125-64</td>
              <td align="center" rowspan="1" colspan="1">16</td>
              <td align="center" rowspan="1" colspan="1">32</td>
              <td align="center" rowspan="1" colspan="1">37.5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Levofloxacin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.125-512</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">512</td>
              <td align="center" rowspan="1" colspan="1">56.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">8-1024</td>
              <td align="center" rowspan="1" colspan="1">512</td>
              <td align="center" rowspan="1" colspan="1">512</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.125-8</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">8</td>
              <td align="center" rowspan="1" colspan="1">37.5</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Azithromycin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.5-&gt; 256</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">56.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.5-&gt; 256</td>
              <td align="center" rowspan="1" colspan="1">128</td>
              <td align="center" rowspan="1" colspan="1">128</td>
              <td align="center" rowspan="1" colspan="1">6.3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Erythromycin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.25-&gt; 256</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">56.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.25-64</td>
              <td align="center" rowspan="1" colspan="1">64</td>
              <td align="center" rowspan="1" colspan="1">64</td>
              <td align="center" rowspan="1" colspan="1">6.3</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Clindamycin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.063-&gt; 256</td>
              <td align="center" rowspan="1" colspan="1">0.125</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">87.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">0.063-&gt; 256</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">&gt;256</td>
              <td align="center" rowspan="1" colspan="1">54.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.063-0.125</td>
              <td align="center" rowspan="1" colspan="1">0.063</td>
              <td align="center" rowspan="1" colspan="1">0.063</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Tobramycin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.25-256</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">81.3</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">0.5-256</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">256</td>
              <td align="center" rowspan="1" colspan="1">13.6</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.5-32</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">93.8</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Tetracycline</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.5-32</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">93.8</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">0.25-64</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">95.5</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.25-0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Rif ampin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.002-0.016</td>
              <td align="center" rowspan="1" colspan="1">0.008</td>
              <td align="center" rowspan="1" colspan="1">0.008</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">0.004-0.125</td>
              <td align="center" rowspan="1" colspan="1">0.008</td>
              <td align="center" rowspan="1" colspan="1">0.008</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.004-0.008</td>
              <td align="center" rowspan="1" colspan="1">0.004</td>
              <td align="center" rowspan="1" colspan="1">0.008</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Vancomycin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">0.5-1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">1</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Linezolid</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">2-4</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">2-4</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">4</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">2</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">Oxacillin</td>
              <td align="left" rowspan="1" colspan="1">MSSA</td>
              <td align="center" rowspan="1" colspan="1">0.25-0.5</td>
              <td align="center" rowspan="1" colspan="1">0.25</td>
              <td align="center" rowspan="1" colspan="1">0.5</td>
              <td align="center" rowspan="1" colspan="1">100</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type II)</td>
              <td align="center" rowspan="1" colspan="1">&gt;8</td>
              <td align="center" rowspan="1" colspan="1">&gt;8</td>
              <td align="center" rowspan="1" colspan="1">&gt;8</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1"/>
              <td align="left" rowspan="1" colspan="1">MRSA (type IV)</td>
              <td align="center" rowspan="1" colspan="1">4-&gt;8</td>
              <td align="center" rowspan="1" colspan="1">&gt;8</td>
              <td align="center" rowspan="1" colspan="1">&gt;8</td>
              <td align="center" rowspan="1" colspan="1">0</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="tf2-1">
            <label>a</label>
            <p>Since besifloxacin was developed as an exclusively topical ophthalmic agent, no breakpoints exist.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>Rifampin was the most potent antimicrobial agent tested for all <italic>S. aureus</italic> isolates with MIC<sub>90</sub> values of 0.008 ug/ml. Among the FQ agents tested, BES was the most potent agent, with MIC<sub>90</sub> values of 4 ng/ml for SCC<italic>mec</italic> type II and MSSA isolates and 0.5&#x3BC;g/ml for SCC<italic>mec</italic> type IV isolates. For all FQ agents tested, the MSSA isolates displayed the broadest MIC ranges. The highest MIC<sub>90</sub> values observed among the SCC<italic>mec</italic> type II isolates and MSSA isolates were 512&#x3BC;g/ml for LVX, &gt; 256&#x3BC;g/ml for AZI, ERY, and CLI, and 256&#x3BC;g/ml for TOB and CIP. In contrast the highest MIC<sub>90</sub> values for SCCmec type IV isolates were 128&#x3BC;g/ml for AZI, 64&#x3BC;g/ml for ERY, and 32&#x3BC;g/ml for CIP.</p>
      <p>The <italic>spa</italic> typing data presented in <xref ref-type="table" rid="tbl3">Table 3</xref> revealed that all 22 SCC<italic>mec</italic> type II isolates, representing four different <italic>spa</italic> types, occurred within the same BURP cluster (spa-CC002) with <italic>spa</italic> type t002 observed most frequently (81.8%; 18/22). Similarly, the 16 SCC<italic>mec</italic> type IV isolates, representing five different <italic>spa</italic> types, occurred within the same BURP cluster (spa-CC008) with <italic>spa</italic> type t008 observed most frequently (75.0%; 12/16). In contrast, the 16 MSSA isolates displayed by far the most diversity in terms of the number of different <italic>spa</italic> types found; with the exception of <italic>spa</italic> type t002, which occurred five times, no other type was represented more than once. The 12 different <italic>spa</italic> types found among the MSSA isolates comprised four BURP clusters (spa-CC002, spa-CC008, spa-CC084, and spa-CC240/773) in addition to three singletons.</p>
      <table-wrap id="tbl3" position="float">
        <label>TABLE 3</label>
        <caption>
          <p><italic>spa</italic> clusters, <italic>spa</italic> types, repeat patterns, and (n) number for ocular <italic>S. aureus.</italic></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th colspan="3" align="left" rowspan="1">MRSA SCC<italic>mec</italic> type II (n=22)</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC002 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t002</td>
              <td align="center" rowspan="1" colspan="1">26-23-17&#x2013;34-17&#x2013;20-17-12&#x2013;17-16</td>
              <td align="center" rowspan="1" colspan="1">(18)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t045</td>
              <td align="center" rowspan="1" colspan="1">26-17&#x2013;20-17-12-17-16</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t067</td>
              <td align="center" rowspan="1" colspan="1">26-23-17&#x2013;34-17&#x2013;20-17-12-17</td>
              <td align="center" rowspan="1" colspan="1">(2)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t242</td>
              <td align="center" rowspan="1" colspan="1">26-23-17-13-17-20-17-12-17-16</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td colspan="3" align="center" rowspan="1">MRSA SCC<italic>mec</italic> type IV (n=16)</td>
            </tr>
            <tr>
              <td colspan="3" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC008 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t008</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;19-12&#x2013;21-17&#x2013;34-24&#x2013;34-22&#x2013;25</td>
              <td align="center" rowspan="1" colspan="1">(12)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t024</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;12&#x2013;21-17&#x2013;34-24&#x2013;34-22&#x2013;25</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t334</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;12&#x2013;21-17&#x2013;34-22&#x2013;25</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t622</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;19-12&#x2013;21-17&#x2013;34-22&#x2013;25</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t1578</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;19-12-21-17&#x2013;34-24&#x2013;34-17</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td colspan="3" align="center" rowspan="1">MSSA (n=16)</td>
            </tr>
            <tr>
              <td colspan="3" rowspan="1">
                <hr/>
              </td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC002 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t002</td>
              <td align="center" rowspan="1" colspan="1">26-23-17&#x2013;34-17&#x2013;20-17-12-17-16</td>
              <td align="center" rowspan="1" colspan="1">(5)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t242</td>
              <td align="center" rowspan="1" colspan="1">26-23-17-13&#x2013;17&#x2013;20-17-12-17-16</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC008 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t008</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;19-12-21-17-34-24&#x2013;34-22-25</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t064</td>
              <td align="center" rowspan="1" colspan="1">11&#x2013;19-12-05-17-34-24-34-22-25</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC084 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t084</td>
              <td align="center" rowspan="1" colspan="1">07-23-12&#x2013;34&#x2013;34-12&#x2013;12&#x2013;23-02-12&#x2013;23</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t346</td>
              <td align="center" rowspan="1" colspan="1">07-23-12-34-12-12&#x2013;23-02-12&#x2013;23</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t491</td>
              <td align="center" rowspan="1" colspan="1">26-23-12-34-34-12-12&#x2013;23-02-12-23</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>spa CC240/773 cluster</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t240</td>
              <td align="center" rowspan="1" colspan="1">04-44-33-31-12-16&#x2013;34-16-12-22&#x2013;34</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t773</td>
              <td align="center" rowspan="1" colspan="1">04-44-33-31-16-12&#x2013;25-22&#x2013;34</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td colspan="3" align="left" rowspan="1">
                <italic>Singletons</italic>
              </td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t004</td>
              <td align="center" rowspan="1" colspan="1">09-02-16-13-13-17-34-16-34</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t005</td>
              <td align="center" rowspan="1" colspan="1">26-23-13&#x2013;23-31-05-17&#x2013;25-17&#x2013;25-16&#x2013;28</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
            <tr>
              <td align="left" rowspan="1" colspan="1">t160</td>
              <td align="center" rowspan="1" colspan="1">07-23-21-24&#x2013;33-22-17</td>
              <td align="center" rowspan="1" colspan="1">(1)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec sec-type="">
      <title>DISCUSSION</title>
      <p>Molecular and microbiological characterizations were conducted to determine whether ocular isolates have traits characteristic for CA-MRSA or HA-MRSA. To our knowledge, no SCC<italic>mec</italic> typing study<xref ref-type="bibr" rid="b13">13</xref> has been conducted on an exclusively ocular set of MRSA isolates. Because these isolates were also part of separate FQ resistance characterization studies among ocular isolates, a substantial fraction of strains tested here (41/56) had elevated FQ MIC values and therefore may not be fully representative of ocular MRSA in general. Nevertheless, because most ocular infections are treated empirically this report of multidrug-resistant strains isolated from the eye with genetic traits of both CA-MRSA and HA-MRSA should be of interest to the ophthalmic community.</p>
      <p>The results of the current study showed that all 38 typeable ocular MRSA isolates tested could be classified as either SCC<italic>mec</italic> type II or SCC<italic>mec</italic> type IV, the predominant cassette types of HA-MRSA and CA-MRSA, respectively.<xref ref-type="bibr" rid="b21">21</xref>,<xref ref-type="bibr" rid="b37">37</xref> Consistent with previous reports,<xref ref-type="bibr" rid="b38">38</xref> all the ocular SCC<italic>mec</italic> type II strains examined here exhibited traits typical for HA-MRSA, including the absence of the PVL toxin and resistance to multiple drug classes (<xref ref-type="table" rid="tbl1">Table 1</xref>). Over 95% of the SCC<italic>mec</italic> type II isolates were resistant to at least four different classes of antimicrobial agents and MIC<sub>50</sub> and MIC<sub>90</sub> values against such agents were elevated in comparison to values observed among the SCC<italic>mec</italic> type IV isolates. The increased resistance to non &#x3B2;-lactam antibacterials found in the SCC<italic>mec</italic> type II isolates may be partly due to the fact that these cassettes contain a variety of additional drug resistance gene elements not found within SCC<italic>mec</italic> type IV cassettes.<xref ref-type="bibr" rid="b39">39</xref></p>
      <p>CA-MRSA isolates have usually been defined as containing SCC<italic>mec</italic> type IV cassettes, expressing PVL, and exhibiting susceptibility to non-&#x3B2;-lactam antimicrobial agents.<xref ref-type="bibr" rid="b21">21</xref>,<xref ref-type="bibr" rid="b40">40</xref> In this study, 16 MRSA isolates were characterized as SCC<italic>mec</italic> type IV isolates and of these 75% were found to contain the PVL genes. In contrast to the SCC<italic>mec</italic> type II isolates, which all showed high level resistance to several classes of antimicrobial agents, all SCC<italic>mec</italic> type IV isolates shared only resistance to &#x3B2;-lactam agents. There were, however, high levels of resistance to other drug classes observed; among the SCC<italic>mec</italic> type IV isolates, susceptibility to the FQ and macrolide classes was only 37.5% and 6.3%, respectively.</p>
      <p>Recently, in a large MRSA surveillance study conducted in San Francisco, Diep et al. found that almost 90% of their USA300 strains (n= 188) were resistant to ERY, over 60% were resistant to CIP, over 24% were resistant to TET, and over 10% were resistant to CLI.<xref ref-type="bibr" rid="b41">41</xref> These data, taken together with our resistance data, indicate that resistance to non-&#x3B2;-lactam antibiotics might be increasing among SCC<italic>mec</italic> type IV isolates. The increased resistance and the fact that 25% of our SCC<italic>mec</italic> type IV isolates did not produce PVL, suggest that the criteria for classifying a MRSA isolate as either CA- or HA-MRSA are blurring. Nonetheless, the MIC<sub>90</sub> values for all antimicrobial agents were equal to or lower for SCC<italic>mec</italic> type IV isolates than for SCC<italic>mec</italic> type II isolates.</p>
      <p>PFGE or <italic>spa</italic> typing can reveal clonal relationships among MRSA isolates. The most observed types in this study were <italic>spa</italic> types t008 and t002 representing the clones USA300 and USA100, respectively. These <italic>spa</italic> types have been frequently reported as common <italic>spa</italic> types found in large surveillance studies worldwide.<xref ref-type="bibr" rid="b42">42</xref>&#x2013;<xref ref-type="bibr" rid="b44">44</xref> In the relative global frequencies database on the Ridom SpaServer website, <italic>spa</italic> types t003 (12.5%), t032 (10.7%), t008 (6.6%), and t002 (5.9%) are listed as the most commonly isolated <italic>spa</italic> types (<ext-link ext-link-type="uri" xlink:href="http://spaserver.ridom.de/frequencies.shtml">http://spaserver.ridom.de/frequencies.shtml</ext-link>, accessed 07 Jun 2010). Although the Ridom database does contain isolates from all over the world, the data set is dominated by European isolates. For example, our analysis of the Ridom database revealed that of the 50 most frequent <italic>spa</italic> types (those with a prevalence of 0.25% or higher), 95.5% of the 59,811 isolates with country of origin listed were from Europe, while only 1.5% originated in the United States. The most common <italic>spa</italic> types among the 898 U.S. isolates were t008 (69.7%), t002 (11.8%), t064 (4.7%), t045 (2.8%), t024 (2.0%), and t242 (1.6%); the same six <italic>spa</italic> types were also identified among the 54 ocular isolates described here. These data support the hypothesis that the <italic>spa</italic> types of ocular <italic>S. aureus</italic> are similar to those isolated from other body sites.</p>
      <p>All MRSA isolates containing the SCC<italic>mec</italic> type II element were either of <italic>spa</italic> type t002 or one of three similar <italic>spa</italic> types that belong to cluster spa-CC002. Type t002 was the founder of this cluster and was, with 18 isolates, the most prevalent <italic>spa</italic> type. Similarly, all strains containing a SCC<italic>mec</italic> type IV element were either <italic>spa</italic> type t008 or one of four <italic>spa</italic> types that are part of the spa-CC008 cluster. Type t008 was the founder of the spa-CC008 cluster and was, with 12 isolates, the second most prevalent <italic>spa</italic> type among MRSA isolates.</p>
      <p><italic>Spa</italic> types t002 and t242 (cluster spa-CC002) and t008 (cluster spa-CC008) were present in the MRSA and the MSSA groups. Several previous reports have documented the in vivo conversions of clinical MSSA to MRSA and vice versa.<xref ref-type="bibr" rid="b45">45</xref>,<xref ref-type="bibr" rid="b46">46</xref> The acquisition or loss of DNA encoding the SCC<italic>mec</italic> cassette may occur more frequently in SCC<italic>mec</italic> type IV isolates than in SCC<italic>mec</italic> type II isolates, presumably due to the smaller, more mobile SCC<italic>mec</italic> type IV cassette.<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b21">21</xref>,<xref ref-type="bibr" rid="b47">47</xref> It remains to be determined if an ancestral strain acquired a specific SCC<italic>mec</italic> element and then diversified into clones with similar <italic>spa</italic> types, or if related strains independently converted from MSSA to MRSA by integrating SCC<italic>mec</italic> elements.<xref ref-type="bibr" rid="b48">48</xref></p>
      <p>In conclusion, the molecular characterization and, to some extent, the antimicrobial phenotypes of the MRSA isolates tested in this study demonstrate that SCC<italic>mec</italic> type II and SCC<italic>mec</italic> type IV isolates generally fit the classical definition of HA- and CA-MRSA strains, respectively. In contrast to MRSA, MSSA isolates were more diverse in their PVL, <italic>spa</italic> type, and antimicrobial susceptibility profiles, whereas the MRSA isolates were less varied with respect to these traits. In particular, the presence of a dominant <italic>spa</italic> type and the similarity between <italic>spa</italic> repeats among isolates with the same SCC<italic>mec</italic> type suggests that <italic>spa</italic> typing may be an additional useful tool when molecularly investigating and classifying ocular MRSA isolates as either CA- or HA-MRSA.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We would like to thank Gary E. Zurenko and Dean L. Shinabarger of Micromyx (Kalamazoo, Michigan, USA) for editorial comments. Parts of this study were presented in poster form at the annual meeting of the Association for Research in Vision and Ophthalmology, Fort Lauderdale, FL.</p>
    </ack>
    <sec>
      <title>Declaration of interest:</title>
      <p>All authors are employees of Bausch &amp; Lomb, Inc., Rochester, NY. The authors alone are responsible for the content and writing of the paper.</p>
    </sec>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="b1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Miller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Diaz</surname>
              <given-names>MG</given-names>
            </name>
            <name>
              <surname>Perez</surname>
              <given-names>EM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of community acquired methicillin resistant Staphylococcus aureus among ocular MRSA isolates</article-title>
          <source>Am J Infect Control</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>E23</fpage>
          <lpage>E24</lpage>
        </element-citation>
      </ref>
      <ref id="b2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jevons</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>&#x201C;Celbenin&#x201D;-resistant staphylococci</article-title>
          <source>Br Med J</source>
          <year>1961</year>
          <volume>1</volume>
          <fpage>124</fpage>
          <lpage>125</lpage>
        </element-citation>
      </ref>
      <ref id="b3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deresinski</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Methicillin-resistant Staphylococcus aureus: An evolutionary, epidemiologic, and therapeutic odyssey</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>562</fpage>
          <lpage>573</lpage>
          <pub-id pub-id-type="pmid">15712079</pub-id>
        </element-citation>
      </ref>
      <ref id="b4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chambers</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>The changing epidemiology of Staphylococcus aureus?</article-title>
          <source>Emerg Infect Dis</source>
          <year>2001</year>
          <volume>7</volume>
          <fpage>178</fpage>
          <lpage>182</lpage>
          <pub-id pub-id-type="pmid">11294701</pub-id>
        </element-citation>
      </ref>
      <ref id="b5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Warshawsky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Gregson</surname>
              <given-names>DB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hospital-and community-based surveillance of methicillin-resistant Staphylococcus aureus: Previous hospitalization is the major risk factor</article-title>
          <source>Infect Control Hosp Epidemiol</source>
          <year>2000</year>
          <volume>21</volume>
          <fpage>724</fpage>
          <lpage>727</lpage>
          <pub-id pub-id-type="pmid">11089657</pub-id>
        </element-citation>
      </ref>
      <ref id="b6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Monnet</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>MacKenzie</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Lopez-Lozano</surname>
              <given-names>JM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000</article-title>
          <source>Emerg Infect Dis</source>
          <year>2004</year>
          <volume>10</volume>
          <fpage>1432</fpage>
          <lpage>1441</lpage>
          <pub-id pub-id-type="pmid">15496245</pub-id>
        </element-citation>
      </ref>
      <ref id="b7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Herold</surname>
              <given-names>BC</given-names>
            </name>
            <name>
              <surname>Immergluck</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Maranan</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk</article-title>
          <source>JAMA</source>
          <year>1998</year>
          <volume>279</volume>
          <fpage>593</fpage>
          <lpage>598</lpage>
          <pub-id pub-id-type="pmid">9486753</pub-id>
        </element-citation>
      </ref>
      <ref id="b8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boyce</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Community-associated methicillin-resistant Staphylococcus aureus as a cause of health care-associated infection</article-title>
          <source>Clin Infect Dis</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>795</fpage>
          <lpage>798</lpage>
          <pub-id pub-id-type="pmid">18266609</pub-id>
        </element-citation>
      </ref>
      <ref id="b9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Seybold</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Kourbatova</surname>
              <given-names>EV</given-names>
            </name>
            <name>
              <surname>Johnson</surname>
              <given-names>JG</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections</article-title>
          <source>Clin Infect Dis</source>
          <year>2006</year>
          <volume>42</volume>
          <fpage>647</fpage>
          <lpage>656</lpage>
          <pub-id pub-id-type="pmid">16447110</pub-id>
        </element-citation>
      </ref>
      <ref id="b10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Popovich</surname>
              <given-names>KJ</given-names>
            </name>
            <name>
              <surname>Weinstein</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Hota</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains?</article-title>
          <source>Clin Infect Dis</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>787</fpage>
          <lpage>794</lpage>
          <pub-id pub-id-type="pmid">18266611</pub-id>
        </element-citation>
      </ref>
      <ref id="b11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fowler</surname>
              <given-names>VG</given-names>
              <suffix>Jr</suffix>
            </name>
            <name>
              <surname>Olsen</surname>
              <given-names>MK</given-names>
            </name>
            <name>
              <surname>Corey</surname>
              <given-names>GR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical identifiers of complicated Staphylococcus aureus bacteremia</article-title>
          <source>Arch Intern Med</source>
          <year>2003</year>
          <volume>163</volume>
          <fpage>2066</fpage>
          <lpage>2072</lpage>
          <pub-id pub-id-type="pmid">14504120</pub-id>
        </element-citation>
      </ref>
      <ref id="b12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>King</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Humphrey</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Wang</surname>
              <given-names>YF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA300 clone as the predominant cause of skin and soft-tissue infections</article-title>
          <source>Ann Intern Med</source>
          <year>2006</year>
          <volume>144</volume>
          <fpage>309</fpage>
          <lpage>317</lpage>
          <pub-id pub-id-type="pmid">16520471</pub-id>
        </element-citation>
      </ref>
      <ref id="b13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rutar</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>HF</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ophthalmic manifestations of infections caused by the USA300 clone of community-associated methicillin-resistant Staphylococcus aureus</article-title>
          <source>Ophthalmology</source>
          <year>2006</year>
          <volume>113</volume>
          <fpage>1455</fpage>
          <lpage>1462</lpage>
          <pub-id pub-id-type="pmid">16766029</pub-id>
        </element-citation>
      </ref>
      <ref id="b14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tsuji</surname>
              <given-names>BT</given-names>
            </name>
            <name>
              <surname>Rybak</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>CM</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Community- and health care-associated methicillin-resistant Staphylococcus aureus: A comparison of molecular epidemiology and antimicrobial activities of various agents</article-title>
          <source>Diagn Microbiol Infect Dis</source>
          <year>2007</year>
          <volume>58</volume>
          <fpage>41</fpage>
          <lpage>47</lpage>
          <pub-id pub-id-type="pmid">17300912</pub-id>
        </element-citation>
      </ref>
      <ref id="b15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mediavilla</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Oliveira</surname>
              <given-names>DC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multiplex realtime PCR for rapid staphylococcal cassette chromosome mec typing</article-title>
          <source>J Clin Microbiol</source>
          <year>2009</year>
          <volume>47</volume>
          <fpage>3692</fpage>
          <lpage>3706</lpage>
          <pub-id pub-id-type="pmid">19726600</pub-id>
        </element-citation>
      </ref>
      <ref id="b16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Katayama</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hiramatsu</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Anew class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2000</year>
          <volume>44</volume>
          <fpage>1549</fpage>
          <lpage>1555</lpage>
          <pub-id pub-id-type="pmid">10817707</pub-id>
        </element-citation>
      </ref>
      <ref id="b17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deurenberg</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Stobberingh</surname>
              <given-names>EE</given-names>
            </name>
          </person-group>
          <article-title>The evolution of Staphylococcus aureus</article-title>
          <source>Infect Genet Evol</source>
          <year>2008</year>
          <volume>8</volume>
          <fpage>747</fpage>
          <lpage>763</lpage>
          <pub-id pub-id-type="pmid">18718557</pub-id>
        </element-citation>
      </ref>
      <ref id="b18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McClure</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Elsayed</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel staphylococcal cassette chromosome mec type carrying class A mec and type 4 ccr gene complexes in a Canadian epidemic strain of methicillin-resistant Staphylococcus aureus</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2009</year>
          <volume>53</volume>
          <fpage>531</fpage>
          <lpage>540</lpage>
          <pub-id pub-id-type="pmid">19064897</pub-id>
        </element-citation>
      </ref>
      <ref id="b19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baba</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Kuroda</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Genome and virulence determinants of high virulence community-acquired MRSA</article-title>
          <source>Lancet</source>
          <year>2002</year>
          <volume>359</volume>
          <fpage>1819</fpage>
          <lpage>1827</lpage>
          <pub-id pub-id-type="pmid">12044378</pub-id>
        </element-citation>
      </ref>
      <ref id="b20">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kilic</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Stratton</surname>
              <given-names>CW</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Antimicrobial susceptibility patterns and staphylococcal cassette chromosome mec types of, as well as Panton-Valentine leukocidin occurrence among, methicillin-resistant Staphylococcus aureus isolates from children and adults in middle Tennessee</article-title>
          <source>J Clin Microbiol</source>
          <year>2006</year>
          <volume>44</volume>
          <fpage>4436</fpage>
          <lpage>4440</lpage>
          <pub-id pub-id-type="pmid">17065272</pub-id>
        </element-citation>
      </ref>
      <ref id="b21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naimi</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>LeDell</surname>
              <given-names>KH</given-names>
            </name>
            <name>
              <surname>Como-Sabetti</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection</article-title>
          <source>JAMA</source>
          <year>2003</year>
          <volume>290</volume>
          <fpage>2976</fpage>
          <lpage>2984</lpage>
          <pub-id pub-id-type="pmid">14665659</pub-id>
        </element-citation>
      </ref>
      <ref id="b22">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vandenesch</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Naimi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Enright</surname>
              <given-names>MC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: Worldwide emergence</article-title>
          <source>Emerg Infect Dis</source>
          <year>2003</year>
          <volume>9</volume>
          <fpage>978</fpage>
          <lpage>984</lpage>
          <pub-id pub-id-type="pmid">12967497</pub-id>
        </element-citation>
      </ref>
      <ref id="b23">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lo</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Lin</surname>
              <given-names>WJ</given-names>
            </name>
            <name>
              <surname>Tseng</surname>
              <given-names>MH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors and molecular analysis of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus colonization in healthy children</article-title>
          <source>Pediatr Infect Dis J</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>713</fpage>
          <lpage>718</lpage>
          <pub-id pub-id-type="pmid">18600194</pub-id>
        </element-citation>
      </ref>
      <ref id="b24">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lina</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Piemont</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Godail-Gamot</surname>
              <given-names>F</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia</article-title>
          <source>Clin Infect Dis</source>
          <year>1999</year>
          <volume>29</volume>
          <fpage>1128</fpage>
          <lpage>1132</lpage>
          <pub-id pub-id-type="pmid">10524952</pub-id>
        </element-citation>
      </ref>
      <ref id="b25">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Etienne</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Croisier</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Charles</surname>
              <given-names>PE</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits</article-title>
          <source>J Infect Dis</source>
          <year>2004</year>
          <volume>190</volume>
          <fpage>1472</fpage>
          <lpage>1475</lpage>
          <pub-id pub-id-type="pmid">15378440</pub-id>
        </element-citation>
      </ref>
      <ref id="b26">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>DeLeo</surname>
              <given-names>FR</given-names>
            </name>
            <name>
              <surname>Otto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Kreiswirth</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Chambers</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>Community-associated methicillin-resistant Staphylococcus aureus</article-title>
          <source>Lancet</source>
          <year>2010</year>
          <volume>375</volume>
          <fpage>1557</fpage>
          <lpage>1568</lpage>
          <pub-id pub-id-type="pmid">20206987</pub-id>
        </element-citation>
      </ref>
      <ref id="b27">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weniger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Berssenbrugge</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of clonal relatedness among the natural population of Staphylococcus aureus strains by using spa sequence typing and the BURP (based upon repeat patterns) algorithm</article-title>
          <source>J Clin Microbiol</source>
          <year>2008</year>
          <volume>46</volume>
          <fpage>2805</fpage>
          <lpage>2808</lpage>
          <pub-id pub-id-type="pmid">18524961</pub-id>
        </element-citation>
      </ref>
      <ref id="b28">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harmsen</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Claus</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Witte</surname>
              <given-names>W</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management</article-title>
          <source>J Clin Microbiol</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>5442</fpage>
          <lpage>5448</lpage>
          <pub-id pub-id-type="pmid">14662923</pub-id>
        </element-citation>
      </ref>
      <ref id="b29">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hallin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Deplano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Denis</surname>
              <given-names>O</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Validation of pulsed-field gel electrophoresis and spa typing for long-term, nationwide epidemiological surveillance studies of Staphylococcus aureus infections</article-title>
          <source>J Clin Microbiol</source>
          <year>2007</year>
          <volume>45</volume>
          <fpage>127</fpage>
          <lpage>133</lpage>
          <pub-id pub-id-type="pmid">17093021</pub-id>
        </element-citation>
      </ref>
      <ref id="b30">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Koreen</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ramaswamy</surname>
              <given-names>SV</given-names>
            </name>
            <name>
              <surname>Graviss</surname>
              <given-names>EA</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>spa typing method for discriminating among Staphylococcus aureus isolates: Implications for use of a single marker to detect genetic micro- and macrovariation</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>42</volume>
          <fpage>792</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="pmid">14766855</pub-id>
        </element-citation>
      </ref>
      <ref id="b31">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellmann</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Weniger</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Berssenbrugge</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Based Upon Repeat Pattern (BURP): An algorithm to characterize the long-term evolution of Staphylococcus aureus populations based on spa polymorphisms</article-title>
          <source>BMC Microbiol</source>
          <year>2007</year>
          <volume>7</volume>
          <fpage>98</fpage>
          <pub-id pub-id-type="pmid">17967176</pub-id>
        </element-citation>
      </ref>
      <ref id="b32">
        <label>32</label>
        <element-citation publication-type="book">
          <collab>Clinical and Laboratory Standards Institute</collab>
          <article-title>Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved Standard, Eighth Edition</article-title>
          <source>CLSI document M7-A8</source>
          <year>2009</year>
          <publisher-loc>Wayne, PA</publisher-loc>
          <publisher-name>CLSI</publisher-name>
        </element-citation>
      </ref>
      <ref id="b33">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Larsen</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Stegger</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sorum</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>spa typing directly from a mec A, spa and pvl multiplex PCR assay&#x2014;A cost-effective improvement for methicillin-resistant Staphylococcus aureus surveillance</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2008</year>
          <volume>14</volume>
          <fpage>611</fpage>
          <lpage>614</lpage>
          <pub-id pub-id-type="pmid">18393997</pub-id>
        </element-citation>
      </ref>
      <ref id="b34">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Sparling</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Chow</surname>
              <given-names>BL</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci</article-title>
          <source>J Clin Microbiol</source>
          <year>2004</year>
          <volume>42</volume>
          <fpage>4947</fpage>
          <lpage>4955</lpage>
          <pub-id pub-id-type="pmid">15528678</pub-id>
        </element-citation>
      </ref>
      <ref id="b35">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>McClure</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>Elsayed</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus</article-title>
          <source>J Clin Microbiol</source>
          <year>2005</year>
          <volume>43</volume>
          <fpage>5026</fpage>
          <lpage>5033</lpage>
          <pub-id pub-id-type="pmid">16207957</pub-id>
        </element-citation>
      </ref>
      <ref id="b36">
        <label>36</label>
        <element-citation publication-type="book">
          <collab>Clinical and Laboratory Standards Institute</collab>
          <article-title>Performance standards for antimicrobial susceptibility testing; Twentieth Informational Supplement</article-title>
          <source>CLSI document M100-S20</source>
          <year>2010</year>
          <publisher-loc>Wayne, PA</publisher-loc>
          <publisher-name>CLSI</publisher-name>
        </element-citation>
      </ref>
      <ref id="b37">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Francis</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Doherty</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Lopatin</surname>
              <given-names>U</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes</article-title>
          <source>Clin Infect Dis</source>
          <year>2005</year>
          <volume>40</volume>
          <fpage>100</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">15614698</pub-id>
        </element-citation>
      </ref>
      <ref id="b38">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kluytmans-Vandenbergh</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Kluytmans</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Community-acquired methicillin-resistant Staphylococcus aureus: Current perspectives</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>9</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">16445719</pub-id>
        </element-citation>
      </ref>
      <ref id="b39">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deurenberg</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Vink</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Kalenic</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The molecular evolution of methicillin-resistant Staphylococcus aureus</article-title>
          <source>Clin Microbiol Infect</source>
          <year>2007</year>
          <volume>13</volume>
          <fpage>222</fpage>
          <lpage>235</lpage>
          <pub-id pub-id-type="pmid">17391376</pub-id>
        </element-citation>
      </ref>
      <ref id="b40">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limbago</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Fosheim</surname>
              <given-names>GE</given-names>
            </name>
            <name>
              <surname>Schoonover</surname>
              <given-names>V</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: A population-based analysis</article-title>
          <source>J Clin Microbiol</source>
          <year>2009</year>
          <volume>47</volume>
          <fpage>1344</fpage>
          <lpage>1351</lpage>
          <pub-id pub-id-type="pmid">19321725</pub-id>
        </element-citation>
      </ref>
      <ref id="b41">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Diep</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>Carleton</surname>
              <given-names>HA</given-names>
            </name>
            <name>
              <surname>Chang</surname>
              <given-names>RF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus</article-title>
          <source>J Infect Dis</source>
          <year>2006</year>
          <volume>193</volume>
          <fpage>1495</fpage>
          <lpage>1503</lpage>
          <pub-id pub-id-type="pmid">16652276</pub-id>
        </element-citation>
      </ref>
      <ref id="b42">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fenner</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Widmer</surname>
              <given-names>AF</given-names>
            </name>
            <name>
              <surname>Dangel</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Distribution of spa types among methicillin-resistant Staphylococcus aureus isolates during a 6-year period at a low-prevalence university hospital</article-title>
          <source>J Med Microbiol</source>
          <year>2008</year>
          <volume>57</volume>
          <fpage>612</fpage>
          <lpage>616</lpage>
          <pub-id pub-id-type="pmid">18436595</pub-id>
        </element-citation>
      </ref>
      <ref id="b43">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Grundmann</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Aanensen</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>van den Wijngaard</surname>
              <given-names>CC</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: A molecular-epidemiological analysis</article-title>
          <source>PLoS Med</source>
          <year>2010</year>
          <volume>7</volume>
          <fpage>e1000215</fpage>
          <pub-id pub-id-type="pmid">20084094</pub-id>
        </element-citation>
      </ref>
      <ref id="b44">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Witte</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Strommenger</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Cuny</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Methicillin-resistant Staphylococcus aureus containing the Panton-Valentine leucocidin gene in Germany in 2005 and 2006</article-title>
          <source>J Antimicrob Chemother</source>
          <year>2007</year>
          <volume>60</volume>
          <fpage>1258</fpage>
          <lpage>1263</lpage>
          <pub-id pub-id-type="pmid">17934203</pub-id>
        </element-citation>
      </ref>
      <ref id="b45">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chlebowicz</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Nganou</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kozytska</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Recombination between ccrC genes in a type V (5C2&amp;5) staphylococcal cassette chromosome mec (SCCmec) of Staphylococcus aureus ST398 leads to conversion from methicillin resistance to methicillin susceptibility in vivo</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2010</year>
          <volume>54</volume>
          <fpage>783</fpage>
          <lpage>791</lpage>
          <pub-id pub-id-type="pmid">19995931</pub-id>
        </element-citation>
      </ref>
      <ref id="b46">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wielders</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Vriens</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Brisse</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected]</article-title>
          <source>Lancet</source>
          <year>2001</year>
          <volume>357</volume>
          <fpage>1674</fpage>
          <lpage>1675</lpage>
          <pub-id pub-id-type="pmid">11425376</pub-id>
        </element-citation>
      </ref>
      <ref id="b47">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jansen</surname>
              <given-names>WT</given-names>
            </name>
            <name>
              <surname>Beitsma</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Koeman</surname>
              <given-names>CJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Novel mobile variants of staphylococcal cassette chromosome mec in Staphylococcus aureus</article-title>
          <source>Antimicrob Agents Chemother</source>
          <year>2006</year>
          <volume>50</volume>
          <fpage>2072</fpage>
          <lpage>2078</lpage>
          <pub-id pub-id-type="pmid">16723568</pub-id>
        </element-citation>
      </ref>
      <ref id="b48">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Enright</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Robinson</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Randle</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)</article-title>
          <source>Proc Natl Acad Sci USA</source>
          <year>2002</year>
          <volume>99</volume>
          <fpage>7687</fpage>
          <lpage>7692</lpage>
          <pub-id pub-id-type="pmid">12032344</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
